Stephen Thomas Davis

This inventor holds 18 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignees: Transtech Pharma, Inc., Smithkline Beecham Corporation, Vtv Therapeutics LLC. Active years: 2002-2015.

USPTO Granted Patents = 18 (Patent Applications = 1)

% Patents Active = 55.6

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 231(Granted Patents)

Company Filing History:

10 out of 49

Transtech Pharma, Inc.

patents

4 out of 2,198

Smithkline Beecham Corporation

High Point Pharmaceuticals, LLC

patents

Years Active: 2002-2015

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9175003 - Substituted azoanthracene derivatives and intermediates for preparation thereof (2015-11-03),

2. 9120813 - Oxadiazoanthracene compounds for the treatment of diabetes (2015-09-01),

3. 8987295 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2015-03-24),

4. 8933222 - Oxadiazoanthracene compounds for the treatment of diabetes (2015-01-13),

5. 8703766 - Oxadiazoanthracene compounds for the treatment of diabetes (2014-04-22),

6. 8524708 - Oxadiazoanthracene compounds for the treatment of diabetes (2013-09-03),

7. 8383644 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2013-02-26),

8. 8377983 - Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors (2013-02-19),

9. 7906507 - Oxadiazoanthracene compounds for the treatment of diabetes (2011-03-15),

10. 7820821 - Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors (2010-10-26),

11. 7790714 - Oxadiazoanthracene compounds for the treatment of diabetes (2010-09-07),

12. 7727983 - Oxadiazoanthracene compounds for the treatment of diabetes (2010-06-01),

13. 7582673 - Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use (2009-09-01),

14. 7105529 - Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects (2006-09-12),

15. 6620818 - Method for reducing the severity of side effects of chemotherapy and/or radiation therapy (2003-09-16),

Title: The Innovative Journey of Stephen Thomas Davis

Introduction: Stephen Thomas Davis, a pioneering inventor based in Durham, NC, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Stephen Thomas Davis holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Stephen Thomas Davis has established himself as a leading figure in the tech industry. His innovative solutions have not only improved efficiency in various sectors but have also set new standards for technological advancement.

Collaborations: Throughout his career, Stephen Thomas Davis has collaborated with top research institutions, leading companies, and brilliant minds in the industry. These collaborations have resulted in the development of cutting-edge technologies that have had a profound impact on society.

Conclusion: Stephen Thomas Davis's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a visionary inventor. His work continues to inspire the next generation of inventors and shape the future of technology.